Company: HCTI
Filing Date: 2025-11-28
Form Type: S-3
Source: 0001213900-25-115888
Chunk: 22

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-28
Form: S-3
Chunk 22
---
 entered into a Sales Agreement (the “ATM Agreement”) with Spartan Capital Securities, LLC (“Spartan”),
as sales agent providing for the sale by the Company of shares of its Common Stock, from time to time, in an “at the market offering”
program through Spartan with certain limitations on the amount of Common Stock that may be offered and sold by the Company as set forth
in the ATM Agreement. The sales, if any, of the shares of Common Stock made under the ATM Agreement will be made by any method permitted
by law deemed to be an “at the market offering” as defined in Rule 415 promulgated under the Securities Act
of 1933, as amended (the “Securities Act”), including sales made directly on or through the Nasdaq Capital Market or on any
other existing trading market for the Common Stock, in negotiated transactions at market prices prevailing at the time of sale or at prices
related to such prevailing market prices, and/or in any other method permitted by law.

The Agreement provides that Spartan will be entitled
to compensation for its services of 3.0% of the gross sales price of all shares of Common Stock sold through Spartan under the ATM Agreement.
The Company has no obligation to sell any shares under the ATM Agreement, and may at any time suspend sales under the ATM Agreement.
The ATM Agreement contains customary representations, warranties and agreements by the Company and indemnification obligations of the
Company. The Company will also reimburse Spartan for certain specified expenses incurred by Spartan in connection with its services under
the ATM Agreement.

<div align='center'>10</div>

THE OFFERING This prospectus relates to the resale or other disposition from time to time by the Selling Stockholders identified in this prospectus of up to 39,473,684 shares of our Common Stock. None of the shares registered hereby are being offered for sale by us.

| Shares of Common Stock offered by the Selling Stockholders |     | 39,473,684 shares of Common Stock issuable upon the conversion of the Notes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Common stock to be outstanding after this offering(1)      |     | 45,346,987 shares of Common Stock, assuming the full conversion of $15,000,000 of Notes at the Floor Price (as defined herein)                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Use of Proceeds                                            |     | The Selling Stockholders will receive all of the proceeds of the sale of shares of Common Stock offered from time to time pursuant to this prospect